"We are MercyOne: a connected system of health care facilities and services dedicated to helping you live your best life."

During the past decade, Mercy Cancer Center at Mercy Medical Center - North Iowa conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 37 clinical trials were completed, i.e. on average, 3700% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mercy Cancer Center at Mercy Medical Center - North Iowa" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 39 trials, followed by "Eastern Cooperative Oncology Group" with 10 trials sponsored, "Radiation Therapy Oncology Group" with 5 trials sponsored, "NSABP Foundation Inc" with 4 trials sponsored and "SWOG Cancer Research Network" with 4 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mercy Cancer Center at Mercy Medical Center - North Iowa" #1 collaborator was "National Cancer Institute (NCI)" with 67 trials as a collaborator, "North Central Cancer Treatment Group" with 5 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator, "NCIC Clinical Trials Group" with 4 trials as a collaborator and "NRG Oncology" with 4 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Mercy Cancer Center at Mercy Medical Center - North Iowa" are "Breast Cancer" (19 trials), "Lung Cancer" (15 trials), "Colorectal Cancer" (7 trials), "Lymphoma" (5 trials) and "Prostate Cancer" (5 trials). Many other conditions were trialed in "Mercy Cancer Center at Mercy Medical Center - North Iowa" in a lesser frequency.

Most popular intervention types in "Mercy Cancer Center at Mercy Medical Center - North Iowa" are "Drug" (55 trials), "Biological" (23 trials), "Other" (17 trials), "Radiation" (13 trials) and "Procedure" (7 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (13 trials), "bevacizumab" (7 trials), "fluorouracil" (6 trials), "radiation therapy" (6 trials) and "rituximab" (6 trials). Other intervention names were less common.

The vast majority of trials in "Mercy Cancer Center at Mercy Medical Center - North Iowa" are 56 trials for "All" genders, 11 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Mercy Cancer Center at Mercy Medical Center - North Iowa". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 59 completed trials in Mercy Cancer Center at Mercy Medical Center - North Iowa, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Mercy Cancer Center at Mercy Medical Center - North Iowa, 2 "Phase 1" clinical trials were conducted, 31 "Phase 2" clinical trials and 31 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".